High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol-Reference-Cited by-同舟云学术

High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol

Published:2005-01 Issue:1 Volume:41 Page:71-80
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Lotz Jean-Pierre,Curé Hervé,Janvier Maud,Asselain Bernard,Morvan François,Legros Michel,Audhuy Bruno,Biron Pierre,Guillemot Maryse,Goubet Jocelyne,Laadem Abderrahmane,Cailliot Christian,Maignan Christine Le,Delozier Thierry,Glaisner Sylvie,Maraninchi Dominique,Roché Henri,Gisselbrecht Christian

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Hormonal therapy and chemotherapy (for metastatic disease);Flamm Honig,1996

2. The importance of dose intensity in chemotherapy of metastatic breast cancer;Hryniuk;J Clin Oncol,1984

3. Dose–response in the treatment of breast cancer: a critical review;Henderson;J Clin Oncol,1988

4. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America;Antman;J Clin Oncol,1997

5. European group for blood and marrow transplantation: blood and marrow activity in Europe in 1996;Gratwohl;Bone Marrow Transpl,1998

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mathematical Oncology to Cancer Systems Medicine: Translation from Academic Pursuit to Individualized Therapy with MORA;Current Cancer Therapy Reviews;2023-02

2. Treating breast cancer with cell-based approaches: an overview;Expert Opinion on Biological Therapy;2017-07-20

3. Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation;Journal of Cancer;2017

4. References;Molecular Approach to Cancer Management;2017

5. Chimiothérapie à hautes doses comme stratégie pour contourner la résistance aux médicaments dans les tumeurs solides;Bulletin du Cancer;2016-10